An Open Label, Comparative, Randomised, Balanced Crossover Trial Comparing Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Breakthrough Pain in Patients With Cancer.
Phase of Trial: Phase III
Latest Information Update: 27 Aug 2014
At a glance
- Drugs Fentanyl (Primary) ; Fentanyl
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Takeda
- 23 Jun 2012 Inclusion and exclusion criteria amended as reported by European Clinical Trials Database record.
- 23 Jun 2012 Additional locations added as reported by European Clinical Trials Database record.
- 04 May 2012 Company added in association field as reported by ClinicalTrials.gov.